BIO Historical Income Statement
| BKYI Stock | USD 0.90 0.02 2.17% |
Historical analysis of BIO Key income statement accounts such as Interest Expense of 207.4 K, Selling General Administrative of 5.1 M or Total Revenue of 5 M can show how well BIO Key International performed in making a profits. Evaluating BIO Key income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of BIO Key's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining BIO Key International latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether BIO Key International is a good buy for the upcoming year.
BIO |
About BIO Income Statement Analysis
BIO Key International Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to BIO Key shareholders. The income statement also shows BIO investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
BIO Key Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts BIO Key International generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of BIO Key International. It is also known as BIO Key overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from BIO Key's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into BIO Key International current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BIO Key International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. As of now, BIO Key's Reconciled Depreciation is decreasing as compared to previous years.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 18K | 30.0K | 218.3K | 207.4K | Depreciation And Amortization | 514.1K | 546.0K | 590.1K | 573.1K |
BIO Key income statement Correlations
Click cells to compare fundamentals
BIO Key Account Relationship Matchups
High Positive Relationship
High Negative Relationship
BIO Key income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 154.0 | 426.9K | 514.1K | 546.0K | 590.1K | 573.1K | |
| Interest Expense | 1.1M | 4.3M | 18K | 30.0K | 218.3K | 207.4K | |
| Selling General Administrative | 5.0M | 5.8M | 6.0M | 9.6M | 8.5M | 5.1M | |
| Total Revenue | 2.3M | 2.8M | 5.1M | 7.0M | 7.8M | 5.0M | |
| Gross Profit | (193.7K) | 2.0M | 3.4M | 5.0M | 1.4M | 1.4M | |
| Other Operating Expenses | 8.8M | 7.7M | 10.1M | 15.4M | 16.6M | 9.2M | |
| Operating Income | (6.6M) | (4.9M) | (5.0M) | (9.7M) | (8.8M) | (8.4M) | |
| Ebit | (6.6M) | (5.3M) | (5.0M) | (11.9M) | (8.4M) | (8.0M) | |
| Research Development | 1.3M | 1.4M | 2.4M | 3.3M | 2.4M | 2.3M | |
| Ebitda | (6.6M) | (4.9M) | (4.5M) | (11.4M) | (7.8M) | (7.5M) | |
| Cost Of Revenue | 2.5M | 794.8K | 1.7M | 2.0M | 6.3M | 6.6M | |
| Total Operating Expenses | 6.4M | 6.9M | 8.4M | 13.3M | 10.3M | 7.5M | |
| Net Income | (14.7M) | (13.6M) | (4.6M) | (10.7M) | (8.5M) | (8.1M) | |
| Income Tax Expense | 64.3K | 3.9M | (496.1K) | 511.3K | (134.0K) | (140.7K) | |
| Income Before Tax | (14.6M) | (9.7M) | (5.1M) | (10.2M) | (8.7M) | (8.2M) | |
| Total Other Income Expense Net | (8.0M) | (4.5M) | (123.9K) | (2.0M) | 170.5K | 179.0K | |
| Net Income Applicable To Common Shares | (8.5M) | (14.6M) | (9.8M) | (5.1M) | (4.6M) | (4.8M) | |
| Net Income From Continuing Ops | (14.6M) | (9.7M) | (5.1M) | (10.2M) | (9.1M) | (9.6M) | |
| Interest Income | 154.0 | 30.6K | 4.1K | 233.0 | 6.0K | 5.7K | |
| Net Interest Income | (1.1M) | (4.3M) | (13.9K) | (29.7K) | (1.3M) | (1.4M) | |
| Reconciled Depreciation | 1.0M | 426.9K | 514.1K | 546.0K | 551.6K | 712.4K |
Currently Active Assets on Macroaxis
When determining whether BIO Key International offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BIO Key's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Key International Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Key International Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BIO Key International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Systems Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BIO Key. If investors know BIO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BIO Key listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (8.66) | Revenue Per Share 6.323 | Quarterly Revenue Growth (0.41) | Return On Assets (0.56) | Return On Equity (4.58) |
The market value of BIO Key International is measured differently than its book value, which is the value of BIO that is recorded on the company's balance sheet. Investors also form their own opinion of BIO Key's value that differs from its market value or its book value, called intrinsic value, which is BIO Key's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BIO Key's market value can be influenced by many factors that don't directly affect BIO Key's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BIO Key's value and its price as these two are different measures arrived at by different means. Investors typically determine if BIO Key is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BIO Key's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.